Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 phase III study: Japan clinical oncology group study (JCOG 0701)

Japanese Journal of Clinical Oncology

Volumn 38, Issue 5, 2008, Pages 387-389

  Nakamura, Kenichi ^a   Kodaira, Takeshi ^b   Shikama, Naoto ^c   Kagami, Yoshikazu ^d   Ishikura, Satoshi ^a   Shibata, Taro ^a   Hiraoka, Masahiro ^e  

^a NATIONAL CANCER CENTER   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinical trials; Dose fractionation; Laryngeal neoplasms; Phase III; Radiotherapy

Indexed keywords

ACCELERATED FRACTIONATION RADIATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVENTIONAL FRACTIONATION RADIATION THERAPY; DISEASE FREE SURVIVAL; HUMAN; INTERMETHOD COMPARISON; JAPAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOICE;

ADULT; AGED; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; GLOTTIS; HUMANS; JAPAN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VOICE DISORDERS;

EID: 44449089921     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn025     Document Type: Article

References (9)

1. Mendenhall WM, Parsons JT, Million RR, Fletcher GH. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 1988;15(6):1267-73.
2. Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1993;26(5):767-72.
3. Parsons JT, Cassisi NJ, Million RR. Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 1984;10(11):2041-51.
4. Van den Bogaert W, Van der Leest A, Rijnders A, Delaere P, Thames H, van der Schueren H. Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer? Radiother Oncol 1995;36(3):177-82.
5. Kim RY. Marks ME, Salter MM. Early-stage glottic cancer: Importance of dose fractionation in radiation therapy. Radiology 1992;182(1): 273-5.
6. Robertson AG, Robertson C, Boyle P, Symonds RP, Wheldon TE. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993;29A(4):501-10.
7. Yu E, Shenouda G, Beaudet MP, Black MJ. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;37(3):587-91.
8. Hodson D, Archibald S, Browman G, Johnston M, Cripps C, Davidson J, et al. Optimum radiation fractionation for T1 N0 glottic (vocal cord) carcinoma evidence summary report #5-4: Program in evidence-based care a cancer care ontario program. www.cancercare.on.ca/accsessPEBC.htm.
9. Crowley J, Green S, Liu PY, Wolf M. Data Monitoring Committees and early stopping guidelines: The Southwest Oncology Group experience. Stat Med 1994;13(13-14):1391-9.